These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38353645)

  • 21. Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state.
    Padwa H; Huang D; Mooney L; Grella CE; Urada D; Bell DS; Bass B; Boustead AE
    Subst Abuse Treat Prev Policy; 2022 May; 17(1):36. PubMed ID: 35527269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential.
    Botsford SL; Yang S; George TP
    Am J Addict; 2020 Jan; 29(1):9-26. PubMed ID: 31577377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mediating roles of coping, sleep, and anxiety motives in cannabis use and problems among returning veterans with PTSD and MDD.
    Metrik J; Jackson K; Bassett SS; Zvolensky MJ; Seal K; Borsari B
    Psychol Addict Behav; 2016 Nov; 30(7):743-754. PubMed ID: 27786514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations among trauma, posttraumatic stress disorder, cannabis use, and cannabis use disorder in a nationally representative epidemiologic sample.
    Kevorkian S; Bonn-Miller MO; Belendiuk K; Carney DM; Roberson-Nay R; Berenz EC
    Psychol Addict Behav; 2015 Sep; 29(3):633-8. PubMed ID: 26415060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide DNA methylation analysis of cannabis use disorder in a veteran cohort enriched for posttraumatic stress disorder.
    Garrett ME; Dennis MF; Bourassa KJ; ; Hauser MA; Kimbrel NA; Beckham JC; Ashley-Koch AE
    Psychiatry Res; 2024 Mar; 333():115757. PubMed ID: 38309009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A Systematic Review.
    Hindocha C; Cousijn J; Rall M; Bloomfield MAP
    J Dual Diagn; 2020; 16(1):120-139. PubMed ID: 31479625
    [No Abstract]   [Full Text] [Related]  

  • 27. Burden of cannabis use and disorder in the U.S. veteran population: Psychiatric comorbidity, suicidality, and service utilization.
    Hill ML; Nichter BM; Norman SB; Loflin M; Pietrzak RH
    J Affect Disord; 2021 Jan; 278():528-535. PubMed ID: 33017681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset.
    Preuss UW; Hesselbrock MN; Hesselbrock VM
    Brain Sci; 2023 Jul; 13(8):. PubMed ID: 37626487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Trauma Cue Exposure and Posttraumatic Stress Disorder (PTSD) on Affect and Cannabis Craving in Cannabis Users With Trauma Histories: Use of Expressive Writing as an Online Cue-Reactivity Paradigm: Effets de l'exposition aux signaux traumatiques et du SSPT sur l'affect et le besoin de cannabis chez les consommateurs de cannabis ayant des antécédents de traumatismes : utilisation de l'écriture expressive comme paradigme de réactivité en ligne.
    DeGrace S; Barrett SP; Yakovenko I; Tibbo PG; Romero-Sanchiz P; Carleton RN; Snooks T; Rudnick A; Stewart SH
    Can J Psychiatry; 2024 May; ():7067437241255104. PubMed ID: 38751068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-traumatic stress and marijuana outcomes: The mediating role of marijuana protective behavioral strategies.
    Jordan HR; Madson MB; Bravo AJ; Pearson MR;
    Subst Abus; 2020; 41(3):375-381. PubMed ID: 31361581
    [No Abstract]   [Full Text] [Related]  

  • 31. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials.
    Wang L; Hong PJ; May C; Rehman Y; Oparin Y; Hong CJ; Hong BY; AminiLari M; Gallo L; Kaushal A; Craigie S; Couban RJ; Kum E; Shanthanna H; Price I; Upadhye S; Ware MA; Campbell F; Buchbinder R; Agoritsas T; Busse JW
    BMJ; 2021 Sep; 374():n1034. PubMed ID: 34497047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of cannabis on non-medical opioid use and symptoms of posttraumatic stress disorder: a nationwide longitudinal VA study.
    De Aquino JP; Sofuoglu M; Stefanovics EA; Rosenheck RA
    Am J Drug Alcohol Abuse; 2020 Nov; 46(6):812-822. PubMed ID: 33035104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review.
    Stanciu CN; Brunette MF; Teja N; Budney AJ
    Psychiatr Serv; 2021 Apr; 72(4):429-436. PubMed ID: 33530732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and correlates of cannabis use in an outpatient VA posttraumatic stress disorder clinic.
    Gentes EL; Schry AR; Hicks TA; Clancy CP; Collie CF; Kirby AC; Dennis MF; Hertzberg MA; Beckham JC; Calhoun PS
    Psychol Addict Behav; 2016 May; 30(3):415-21. PubMed ID: 27214172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective.
    Cooper ZD; Craft RM
    Neuropsychopharmacology; 2018 Jan; 43(1):34-51. PubMed ID: 28811670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis.
    Coventry PA; Meader N; Melton H; Temple M; Dale H; Wright K; Cloitre M; Karatzias T; Bisson J; Roberts NP; Brown JVE; Barbui C; Churchill R; Lovell K; McMillan D; Gilbody S
    PLoS Med; 2020 Aug; 17(8):e1003262. PubMed ID: 32813696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positive posttraumatic stress disorder screens among first-time medical cannabis patients: prevalence and association with other substance use.
    Bohnert KM; Perron BE; Ashrafioun L; Kleinberg F; Jannausch M; Ilgen MA
    Addict Behav; 2014 Oct; 39(10):1414-7. PubMed ID: 24930048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Cannabis and Cannabinoids in Patients With Cancer.
    Sawtelle L; Holle LM
    Ann Pharmacother; 2021 Jul; 55(7):870-890. PubMed ID: 33070617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabis and neuropsychiatry, 1: benefits and risks.
    Andrade C
    J Clin Psychiatry; 2016 May; 77(5):e551-4. PubMed ID: 27249079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.